Background: Growth failure often precedes secondary infections in HIV-infected infants and children, suggesting that inadequate protein deposition may be an early manifestation of infection by the virus. However, the protein metabolic response elicited by the virus in young children is unknown. Objective: We compared children with HIV infection and agematched children without HIV infection with regard to wholebody and splanchnic protein kinetics and synthesis of acute phase proteins (APPs). Design: Whole-body and splanchnic leucine kinetics and fractional and absolute synthesis rates of 2 positive and 4 negative APPs were measured in 6 asymptomatic, HIV-infected children (4 males and 2 females) aged 6-17 mo and 4 uninfected children (3 females and 1 male) aged 7-9 mo who were in the fed state. Results: Compared with the control children, the HIV-infected children had significantly lower dietary energy and protein intakes and leucine balance and significantly faster leucine flux and fractional splanchnic leucine extraction; there was no significant difference between the groups in leucine oxidation rates. The HIVinfected children also had significantly higher plasma concentrations and absolute synthesis rates of the positive APPs and a significantly higher fractional synthesis rate of fibrinogen. The concentrations of 2 of the 4 negative APPs, albumin and HDL apolipoprotein A-I, were significantly lower in the HIV-infected children but were not associated with slower synthesis rates.
INTRODUCTION
Loss of lean body mass is a common finding in adults with AIDS, and in these patients, loss of lean body mass is a major predictor of both morbidity and mortality (1) (2) (3) . For example, a lean body mass < 66% of the expected value is a strong predictor of death (2) . Reduced food intake, nutrient malabsorption, elevated resting energy expenditure, and altered protein and lipid metabolism are mechanisms that appear to contribute to this loss of lean body mass (4) (5) (6) (7) (8) .
Interestingly, loss of lean body mass is not a common finding in asymptomatic, HIV-infected adults, ie, those without secondary infections (8, 9) . Studies in such patients, like those in patients with other stressed states, showed faster rates of whole-body protein turnover in those patients than in healthy control subjects. However, dietary protein intake and net rates of protein catabolism are similar to those observed in healthy control subjects. Hence, protein balance is positive (8, 9) .
In contrast, growth failure secondary to low rates of lean tissue deposition is common in infants and young children with HIV infection, including those without secondary infections (10) (11) (12) . Moreover, early growth failure is an important predictor of a poor prognosis (13, 14) . Thus, it appears that HIV infection, per se, induces a disturbance in protein metabolism that leads to reduced protein deposition in infants and young children but not in adults. However, little is known about protein metabolism in asymptomatic, HIV-infected infants and young children.
This study was designed to determine the effect of HIV infection in the absence of secondary infections on the whole-body protein kinetics of infants and young children. The subjects were studied in the fed state to determine the effect of the virus on splanchnic uptake and utilization of dietary protein as well as on whole-body protein kinetics. Finally, the rates of synthesis of positive and negative acute phase proteins (APPs) were measured to determine whether HIV infection without secondary infection elicits an APP response.
SUBJECTS AND METHODS

Subjects
Five infants (3 males and 2 females) and 1 young male child with perinatally transmitted HIV infection and 4 uninfected infants (1 male and 3 females) who were also born to HIVinfected mothers participated in the study. The HIV-positive children were diagnosed with the use of HIV culture and polymerase 1 There were no significant differences between the HIV-infected subjects and the uninfected subjects.
chain reaction before 1 mo of age, except for subject 2 (see Table 1 ), who was diagnosed at 6 mo of age. The classification of the children according to criteria from the Centers for Disease Control and Prevention (15) ranged from no clinical symptoms and no suppression of CD4 count (N1) to previous episodes of secondary infections and markedly suppressed CD4 counts (C3).
At the time of the study, none of the HIV-infected subjects had any signs or symptoms of secondary infections. All were being treated with antibiotics: 5 were being treated with prophylactic sulfamethoxazole:trimethoprim and one, although free of symptoms at the time of the study, was completing a course of erythromycin:sulfisoxazole for an earlier acute infection. Four subjects were being treated with the antifungal nystatin, 4 with antiviral medications, 3 with azydothymidine (AZT), and 1 with stavudine ( Table 1) . The HIV-infected children had a mean age of 9 mo ( Table 2 ). According to the Wellcome Classification (16), 3 of the 6 HIVinfected children with body weight-for-age < 80% of the expected value were wasted. On the basis of their weight-for-length, 2 of the 3 undernourished children were also stunted. Four uninfected children with a socioeconomic background similar to that of the HIV-infected children were recruited as control subjects. The control subjects had a mean age of 8 mo and a mean body weight-for-age of 91% of the expected value. They were deemed to be in good health on the basis of a complete medical history and physical examination. On the basis of 3-d dietary intake records, the mean (± SD) habitual energy and protein intakes of the HIV-infected subjects (70 ± 10 kcal · kg Ϫ1 · d Ϫ1 and 1. 
Experimental protocol
The study was performed in the Pediatric General Clinical Research Center of Texas Children's Hospital. The children were admitted to the Pediatric General Clinical Research Center the day before the experiment was performed. The experiment commenced the following morning. During the experiment, the subjects received hourly feeds equivalent to their habitual intakes for that portion of the day to ensure that the same amount of energy and protein were given during the course of the isotope infusions. The feeds were started 2 h before the isotope infusions commenced. The mean energy and protein intakes of the HIV-infected group during the study period were 4.2 ± 0.5 kcal · kg Ϫ1 · h Ϫ1 and 96 ± 21 mg · kg Ϫ1 · h Ϫ1 , respectively; the mean intakes of the control group were 7.0 ± 0.5 kcal · kg Ϫ1 · h Ϫ1 and 140 ± 12 mg · kg Ϫ1 · h Ϫ1 , respectively. Whole-body and splanchnic leucine kinetics and the rates of synthesis of positive and negative APPs were determined by the simultaneous infusion of Ϫ1 · h Ϫ1 ) was started and maintained for 6 h. The oral dose of isotope was given at 30-min intervals. A primed constant intravenous infusion of NaH 13 CO 3 (priming dose = 4.5 mol/kg, intravenous infusion at 6 mol · kg Ϫ1 · h Ϫ1 ) also was started and maintained for 2 h. After 1 h, 4 breath samples were collected at 20-min intervals to the end of the NaH 13 CO 3 infusion. A primed constant intravenous infusion of [1- 13 C]leucine (priming dose = 13 mol/kg, intravenous infusion at 13 mol · kg Ϫ1 · h Ϫ1 ) was then started and maintained for 4 h. Additional 1.5-mL blood samples were obtained at 3, 4, and 6 h, and 0.5-mL blood samples were obtained at 5.25, 5.5, and 5.75 h. Breath samples were also collected at the latter times, as well as at 6 h.
Sample analyses
The blood samples were drawn into prechilled tubes containing sodium EDTA and a cocktail of sodium azide, merthiolate, and soybean trypsin inhibitor. They were centrifuged immediately at 1000 ϫ g and 4 ЊC for 10 min, and the plasma was removed and stored immediately at Ϫ70 ЊC until analyzed.
Plasma concentrations of 6 proteins [albumin, HDL apolipoprotein (apo) A-I, retinol-binding protein (RBP), transthyretin, ␣ 1 -antitrypsin, and fibrinogen] were measured by using radial immunodiffusion with NL RID kits (The Binding Site, San Diego). Albumin, fibrinogen, VLDL apo B-100, and HDL apo A-I were extracted from plasma as previously described (17) . Transthyretin and ␣ 1 -antitrypsin were isolated from plasma by sequential immunoprecipitation with anti-human transthyretin and ␣ 1 -antitrypsin (Behring, Somerville, NJ) as previously described (18) . The immunoprecipitates and protein precipitates were subjected to sodium dodecyl sulfate-gel electrophoresis to separate the particular protein from its specific antibody and to separate apo A-I from HDL. A pure standard of the protein (Sigma, St Louis) and low-molecular-weight standards (Biorad Laboratories, Richmond, CA) were also included in the gel (18) . After staining with Coomassie brilliant blue dye, the bands corresponding to the protein standard were cut out and washed several times. The dried protein precipitates and gel bands were hydrolyzed in a 6-mol HCl/L solution at 110 ЊC for 12 h. Amino acids released from hydrolysis of the proteins and plasma amino acids were extracted by cation-exchange chromatography and converted to the n-propyl ester heptafluorobutyramide derivative. The tracer-tracee ratio of leucine was measured by negative chemical ionization gas chromatography-mass spectrometric analysis on a Hewlett-Packard 5890 quadrupole mass spectrometer (Hewlett-Packard, Palo Alto, CA) with selective monitoring of ions having mass-to-charge ratios of 349-352. The tracer-tracee ratio of plasma ␣-ketoisocaproic acid (␣-KICA) were measured by negative chemical ionization gas chromatography-mass spectrometric analysis of its pentafluorobenzyl derivative with selective monitoring of ions having mass-to-charge ratios of 129-132. The breath samples were analyzed in duplicate for 13 C abundance in carbon dioxide by gas isotope ratio mass spectrometry (Europa Scientific, Crewe, United Kingdom) with selective monitoring of ions having massto-charge ratios of 44 and 45.
Calculations
Carbon dioxide flux (RaCO 2 ) was calculated from the steady state equation:
where E inf and E b are the isotopic enrichments (atom percent excess) of bicarbonate in the infusate and of carbon dioxide in expired breath, respectively, at isotopic steady state, and i is the rate of infusion of the tracer in mol · kg Ϫ1 · h Ϫ1 . Whole-body and splanchnic leucine kinetics were calculated as previously described (19) . At isotopic steady state, the fraction of the intragastric tracer that enters the systemic circulation (sampled compartment) is given by the ratio of the plasma tracer-tracee ratio of the intragastric tracer to the tracer-tracee ratio of the intravenous tracer, normalized for the infusion rates of the tracers. This fraction is given by
where E pIG is the plateau tracer-tracee ratio of the intragastric (IG) tracer, E pIV is the plateau tracer-tracee ratio of the intravenous (IV) tracer, i IV is the rate of the intravenous tracer infusion times the enrichment of the intravenous tracer, and i IG is the rate of the intragastric tracer infusion times the enrichment of the intragastric tracer. Thus the percentage of intragastric tracer and of dietary leucine extracted by the splanchnic tissues will be
Splanchnic leucine use (Leu splan ) was calculated as the product of the fraction of leucine tracer extracted by the splanchnic tissues and enteral leucine intake:
Total leucine flux (Q) was calculated as
where E p[ 13 C] Ϫ KICA is the plateau enrichment of KICA derived from the [ 13 C]leucine tracer. Leucine oxidation (Leu ox ) was calculated as follows:
where Ra 13 CO 2 is the rate of production of labeled carbon dioxide (obtained from the product of RaCO 2 and the plateau isotopic enrichment of expired carbon dioxide during the [ 13 C]leucine infusion). Leucine used for protein synthesis (Leu syn ) was calculated as leucine flux minus leucine oxidation:
Leucine derived from protein breakdown (Leu brk ) was calculated as the difference between leucine flux and all sources of leucine intake:
Leucine balance (Leu bal ) was calculated as the difference between leucine intake and leucine oxidation:
The fractional synthesis rate (FSR) of each protein was calculated by using the precursor-product equation:
where E t 6 Ϫ E t 4 is the increase in isotopic enrichment of albumin (or transthyretin, RBP, HDL apo A-I, fibrinogen, or ␣ 1 -antitrypsin)-bound leucine over the period t 6 Ϫ t 4 of the infusion, and E pl is the plateau isotopic enrichment of VLDL apo B-100-bound leucine. In this calculation, the plateau enrichment of VLDL apo B-100-bound leucine in plasma is assumed to represent the enrichment of the intrahepatic leucine pool from which the APPs are synthesized (17) .
The absolute intravascular absolute synthesis rate (IV ASR) of albumin (or RBP, transthyretin, HDL apo A-I, fibrinogen, or ␣ 1 -antitrypsin) was estimated as the product of FSR and the intravascular mass of the protein:
where the intravascular mass of a protein is the product of the plasma volume and the plasma concentration of the protein. A plasma volume of 60 mL/kg was used on the basis of measurements done with the dye dilution technique of Gibson and Evans (20) in a comparable group of children after recovery from severe malnutrition (21) .
Statistics
Data are expressed as means ± SEMs. Differences between groups were detected by the unpaired t test. Statistical significance was set at P < 0.05. Pearson correlations between outcome variables were performed with the use of GRAPHPAD INSTAT version 3 (GraphPad Software Inc, San Diego).
RESULTS
Leucine kinetics
Although the HIV-infected children had significantly lower leucine intakes (P < 0.01) than did the uninfected children, leucine oxidation did not differ significantly between the 2 groups because the HIV-infected group oxidized 81 ± 10% of total leucine intake whereas the control group oxidized only 58 ± 5% (Figure 2) . As a consequence, leucine balance was significantly lower (P < 0.01) in the HIV-infected subjects than in the uninfected subjects. Whole-body endogenous leucine flux, ie, leucine flux derived from protein breakdown, was significantly faster (P < 0.05) in the HIV-infected group. However, there was no significant difference in nonoxidative leucine flux, ie, leucine used for protein synthesis, between the 2 groups (Figure 3) . In the HIV-infected group there was a significant correlation between energy intake and leucine balance (r = 0.98, P < 0.004). There were also tendencies for positive and negative correlations between energy intake and nonoxidative leucine flux (r = 0.78, P = 0.11) and endogenous leucine flux (r = Ϫ0.70, P = 0.18), respectively.
Despite the significantly lower (P < 0.01) enteral leucine intake of the HIV-infected group (Figure 4) , leucine uptakes by splanchnic tissue were not significantly different between the 2 groups because the fraction of enteral leucine extracted by the splanchnic tissues of the HIV-infected children was significantly greater (P < 0.05).
Positive acute phase proteins
The HIV-infected group had significantly higher plasma fibrinogen (P < 0.01) and ␣ 1 -antitrypsin (P < 0.001) concentrations than did the uninfected group ( Table 3) . The larger plasma pools FIGURE 2. Mean (± SEM) total leucine intake, oxidation, and balance in 6 asymptomatic, HIV-infected children and 4 uninfected children who were in the fed state.
* Significantly different from uninfected, P < 0.01 (unpaired t test). of fibrinogen and ␣ 1 -antitrypsin in the HIV-infected group were associated with ASRs that were significantly faster than those of the uninfected group.
Negative acute phase proteins
Plasma concentrations of albumin and HDL apo A-I were significantly lower (P < 0.05) in the HIV-infected group than in the uninfected group. The lower plasma HDL apo A-I concentration of the HIVinfected group was associated with a significantly faster FSR (P < 0.01), and there was a trend toward a faster ASR (P = 0.09). There were no significant differences between the 2 groups in either the plasma concentrations or the FSRs and ASRs of transthyretin and RBP (Table 3) .
DISCUSSION
Studies of infants who were born to HIV-infected mothers and subsequently became HIV positive showed that the infants' birth weights were lower than those of infants who remained HIV negative and that the HIV-positive infants grew less rapidly than did HIV-negative infants (10-13). These observations suggest that growth retardation may have begun in utero and continued during the asymptomatic phase of the infection. The observation that unexplained weight loss often precedes secondary infection further suggests that a decrease in protein deposition may be an early manifestation of infection by the virus (10, 12) . The present finding of a lower leucine balance in the asymptomatic, HIV-infected children than in the uninfected children supports such a suggestion.
Two factors could contribute to the lower protein balance, a lower dietary intake of energy and protein and a greater rate of protein oxidation relative to intake. Whereas the control group, whose mean protein intake (2.25 ± 0.2 g · kg Ϫ1 · d Ϫ1 ) was 45% greater than the recommended dietary allowance (RDA; 22), oxidized only 58% of their leucine intake, the HIV-infected group, whose protein intake (1.5 g · kg Ϫ1 · d Ϫ1 ) was equal to the RDA, oxidized 81% of their leucine intake. In other words, the uninfected group used Ϸ42% of their leucine intake to synthesize new protein, but the HIV-infected group used only Ϸ19%. This lower availability of dietary leucine for protein synthesis in the HIVinfected children, combined with their faster endogenous leucine flux, which is indicative of greater whole-body proteolysis, suggests that infection by the virus per se elicits the same changes in whole-body protein metabolism as do other conditions of stress (23, 24) . On the other hand, our present finding of a significant correlation between energy intake and leucine balance and the finding of others that a low energy intake has negative effects on protein balance (25) suggest that the lower leucine (hence, protein) balance of the HIV-infected children is due to their lower energy intakes (70 kcal · kg Ϫ1 · d Ϫ1 , or 26% lower than the RDA for energy, compared with 112 kcal · kg Ϫ1 · d Ϫ1 , or 18% higher than the RDA, in the control children). If this suggestion is true, then increasing the energy intakes of HIV-infected children may improve their protein balance and thereby prevent growth failure. * Significantly different from uninfected, P < 0.01 (unpaired t test).
TABLE 3
Plasma concentrations and fractional and absolute synthesis rates of positive and negative acute phase proteins (APPs) in HIV-infected (n = 6) and uninfected children (n = 4) We are not aware of other studies of protein metabolism in asymptomatic, HIV-infected children. There are, however, 2 reports of similar studies in adults that used the same tracer technique that we used in our study (8, 9) . Both studies, however, reported no differences in the habitual dietary intakes of energy and protein between asymptomatic, HIV-infected adults and uninfected control subjects; hence, their findings cannot be directly compared with those of the present study. Nevertheless, in agreement with our present findings, both studies reported faster rates of protein breakdown in HIV-infected subjects than in control subjects (8, 9) . Also in agreement with our present findings, 1 of the 2 studies, which was performed with subjects in the fed state, reported no differences in leucine oxidation rate and leucine utilized for protein synthesis (9) . Unlike our present finding of a reduced leucine balance in the HIV-infected subjects, however, the 2 studies reported no difference in balance between the asymptomatic, HIV-infected adults and the control subjects. These findings further support the thesis that the deficient energy intakes of the HIV-infected children in the present study may have been the underlying cause of their lower protein balance.
Interestingly, splanchnic leucine uptakes (Ϸ30 mol · kg Ϫ1 · h Ϫ1 ) did not differ significantly between the 2 groups of children despite the HIV-infected children having an enteral leucine intake that was 44 mol · kg Ϫ1 · h Ϫ1 lower than that of the uninfected children. This comparable leucine uptake was achieved by a higher fractional rate of extraction of enteral leucine by the HIV-infected group. A similar finding has been reported for the splanchnic uptake of lysine in piglets fed either a highprotein (23%) or a low-protein (9.2%) diet (26) . These findings suggest that the amino acid requirement and, hence, the protein requirement of organs constituting the splanchnic bed are the same in the 2 groups of children and that this requirement is satisfied by first-pass splanchnic uptake regardless of dietary protein intake.
In an earlier study in asymptomatic, HIV-infected adults, we found that infection by the virus alone elicits a different APP response than that elicited by bacterial infections: the higher concentrations and faster synthesis rates of the positive APPs were not accompanied by lower concentrations and slower synthesis rates of most of the negative APPs (17) . Only plasma HDL apo A-I concentrations were significantly lower in the HIV-infected group than in the uninfected group despite a significantly faster FSR in the HIV-infected group and no significant difference between theconcentrations of 2 of the 4 negative APPs, albumin and HDL apo A-I, were significantly lower in the HIV-infected children, these were not associated with slower synthesis rates. These results suggest that HIV infection does elicit an APP response. However, the response is atypical because the higher concentrations and faster synthesis rates of the positive APPs are not accompanied by lower concentrations of all the negative APPs.
In agreement with our previous findings in HIV-infected adults (17) , plasma HDL apo A-I concentrations were significantly lower in the HIV-infected children than in the uninfected children despite a faster FSR and a trend toward a faster ASR (P = 0.09). Because the pool size of a plasma protein is determined by the balance between its rates of synthesis and catabolism (or loss from the intravascular space), our findings suggest that the lower HDL apo A-I and albumin concentrations in the asymptomatic, HIVinfected children result from faster rates of catabolism or of loss from the intravascular space relative to the rate of synthesis. The lower plasma HDL apo A-I concentrations also suggest that cholesterol transport and, hence, metabolism may be impaired in HIV-infected patients even in the absence of secondary infections. This suggestion is supported by the lower plasma concentrations of total and HDL cholesterol, as well as of HDL apo A-I, reported by Grunfeld et al (5) in symptom-free, HIV-infected adults before the onset of hypertriglyceridemia.
Our present and previous findings (17) of similar or faster FSRs and ASRs of the negative APPs in asymptomatic, HIVinfected subjects refutes the belief that the lower plasma concentrations of negative APPs induced by stressed states are due to reduced synthesis of these proteins (27) . These findings in HIV-infected subjects are further supported by our finding that the lower albumin concentrations in marasmic children were accompanied by a faster albumin FSR when the children were also stressed by infections than when their infections were cleared (28) . Similarly, Mansoor et al (29) reported that the hypoalbuminemia of head trauma subjects was accompanied by a 60% increase in the rate of albumin synthesis during the acute response to head trauma. Together, these findings suggest that the stress of infection, inflammation, and injury does not suppress the synthesis rate of negative APPs. In all likelihood, concentrations of albumin and of other negative APPs decrease precipitously in response to infections, severe trauma, and inflammation because of an increased transcapillary escape rate and an increased catabolic rate (30, 31) .
Finally, it can be argued that the present findings should be interpreted with caution because of the small sample size. However, the data reported for both leucine kinetics and the APPs in the HIV-infected children are in close agreement with the findings of larger studies in HIV-infected adults (5, 8, 9, 17) , which suggests that the findings are valid despite the small number of subjects studied.
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